Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190265 (US9175357, 5827) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet  | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.60E+3 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190264 (US9175357, 5826) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.08E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190261 (US9175357, 5788) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.65E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190266 (US9175357, 5830) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.65E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190262 (US9175357, 5791) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 1.85E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190259 (US9175357, 5785) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.95E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190263 (US9175357, 5792) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.12E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190260 (US9175357, 5786) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.47E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190258 (US9175357, 5756) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.90E+4 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190256 (US9175357, 5753) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 1.04E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190257 (US9175357, 5754) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem Similars | US Patent | n/a | n/a | 1.25E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190253 (US9175357, 5603) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.50E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190254 (US9175357, 5604) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190249 (US9175357, 5598) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190246 (US9175357, 5594) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.50E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190244 (US9175357, 5591) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.75E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190245 (US9175357, 5593) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 3.80E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190252 (US9175357, 5601) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 4.00E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190247 (US9175357, 5595) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.75E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190248 (US9175357, 5597) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.00E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190251 (US9175357, 5600) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190255 (US9175357, 5607) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >6.00E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Serine/threonine-protein kinase PLK1 (Homo sapiens (Human)) | BDBM190250 (US9175357, 5599) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.00E+5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
UNIVERSITY OF SOUTH CAROLINA US Patent | Assay Description The buffer composition was 50 mM Tris, 200 mM NaCl, 2.0 mM DTT, and 0.005% Tween 20 (pH 8.0). Fragment ligated inhibitors and comparison peptides to ... | US Patent US9175357 (2015) BindingDB Entry DOI: 10.7270/Q2V40T14 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
